In a study by Holen et al., OPG was shown to be an endocrine survival factor in MDA-MB-436 and MDA-MB-231 human breast cancer cells by significantly reducing TRAIL-induced apoptosis in vitro [27]. The gene discussed is TNFSF10; the disease is breast carcinoma.